Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
doi:10.1111/j.1471-4159.2006.03693.x PMID: 16539679 4
The results demonstrated that citicoline significantly limited cognitive impairments in the domains of attention and executive functions and temporal orientation at 6 and 12 months post-stroke in treated compared to untreated patients (97)
Levodopa, the most potent symptomatic therapy, markedly improves motor symptoms, yet it comes with considerable adverse reactions (9, 10)
Until human clinical trials (the kind the FDAs July 2026 PCAC consultation is partly designed to assess the case for) produce safety and efficacy data in actual populations of users, the gap between what BPC-157 might do and what is documented that it does in people remains the most important thing to understand about it.
Remember, heat, light, and agitation are the enemies of peptide stability
